Four-week direct-acting antiviral prophylaxis for kidney transplantation from hepatitis C-viremic donors to hepatitis C-negative recipients: An open-label non-randomized study

por Durand, Christine M., Barnaba, Brittany, Yu, Sile, Brown, Diane M., Chattergoon, Michael A., Bair, Nichole, Naqvi, Fizza F., Sulkowski, Mark, Segev, Dorry L., Desai, Niraj M.
Publicado no Ann Intern Med (2020)

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial

por Durand, Christine M., Bowring, Mary G., Brown, Diane M., Chattergoon, Michael A., Massaccesi, Guido, Bair, Nichole, Wesson, Russell, Reyad, Ashraf, Naqvi, Fizza F., Ostrander, Darin, Sugarman, Jeremy, Segev, Dorry L., Sulkowski, Mark, Desai, Niraj M.
Publicado no Ann Intern Med (2018)